License and Asset Transfer Agreement Sample Contracts

LICENSE AND ASSET TRANSFER AGREEMENT BY AND BETWEEN ALZA CORPORATION AND INCLINE THERAPEUTICS, INC.

License and Asset Transfer Agreement • May 10th, 2013 • Medicines Co /De • Pharmaceutical preparations • New York

• Contract Type
  License and Asset Transfer Agreement
• Filed
  May 10th, 2013
• Company
  Medicines Co /De
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [*****] Redacted portions filed separately with the SEC pursuant to the confidential treatment request LICENSE AND ASSET TRANSFER AGREEMENT

License and Asset Transfer Agreement • May 15th, 2012 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York

• Contract Type
  License and Asset Transfer Agreement
• Filed
  May 15th, 2012
• Company
  IntelGenx Technologies Corp.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS LICENSE AND ASSET TRANSFER AGREEMENT (this “Agreement”) is made and entered into as of February 3, 2012 (the “Effective Date”), by and between IntelGenx Corp., a Canadian corporation (“IntelGenx”), and Edgemont Pharmaceuticals, LLC., an US company (“Edgemont”). IntelGenx and Edgemont each may be referred to herein individually as a “Party” or collectively as the “Parties”.

Portions of this exhibit marked [*] are requested to be treated confidentially. CONFIDENTIAL LICENSE AND ASSET TRANSFER AGREEMENT BY AND BETWEEN ALZA CORPORATION AND JANSSEN PHARMACEUTICA, NV AND FURIEX PHARMACEUTICALS, INC., AND GENUPRO, INC. (A...

License and Asset Transfer Agreement • August 7th, 2012 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  License and Asset Transfer Agreement
• Filed
  August 7th, 2012
• Company
  Furiex Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This License and Asset Transfer Agreement (the “Agreement”), by and between ALZA CORPORATION, a company incorporated in the State of Delaware and having offices at 700 Eubanks Drive, Vacaville, California 95688 and JANSSEN PHARMACEUTICA NV, a corporation organised under the laws of the Kingdom of Belgium and having its principal place of business at Turnhoutseweg 30, B-2340 Beerse, Belgium (“JANSSEN”) (collectively “ALZA”), and FURIEX PHARMACEUTICALS, INC., a company incorporated in the State of Delaware and having its registered office at 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560 (“FURIEX”) and GenuPro, Inc. (“GENUPRO”), a wholly-owned subsidiary of FURIEX organized under the laws of the State of North Carolina and having its registered office at 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, is entered into as of the date of signature by the last Party to sign below and is effective upon the satisfaction of the conditions set forth in Section 2 below (the “E